1<!DOCTYPE html>
2
3Anonymous
4/bestp
5/bestp/domrep.nsf
687B1FEF42F766EFE85256F6C0066690F
8
9
10
11
12
13
140
15
16
17/bestp/domrep.nsf/products/white-paper-effectiveness-of-pharmaceutical-lifecycle-management-tactics?opendocument
18
19opendocument
2052.23.234.7
21
22
23www.best-in-class.com
24/bestp/domrep.nsf
25RAS




Products & Services

White Paper: Effectiveness of Pharmaceutical Lifecycle Management Tactics

Whitepaper Image

ID: BEB-11


Pages/Slides: 7


Published: Pre-2014


Delivery Format: PDF


 

License Options:
close

Single User: Authorizes use by the person who places the order or for whom the order was placed.

Sitewide: Authorizes use of the report for a geographic site. All people at site can view the report for a year and copies can be printed.

Corporate: Authorizes use for the entire company for a year and copies can be printed. No limitations for usage inside the company.




Download White Paper

 

919-403-0251

  • STUDY OVERVIEW
  • BENCHMARK CLASS

Please click on
"Buy Now" to obtain the white paper on "Effectiveness of Pharmaceutical Lifecycle Management Tactics."
If you would like to purchase the full study this summary is based on click here.

Industries Profiled:
Pharmaceutical; Chemical; Biotech; Health Care; Medical Device; Manufacturing; Consumer Products; Diagnostic


Companies Profiled:
Abbott Laboratories; Solvay America; Sanofi-Synthelabo Inc.; Pfizer; Ortho Biotech; Organon; Novartis; Eli Lilly and Company; IVAX; Baxter Healthcare; Bayer